These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22003912)

  • 21. An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Chang WC; Hung SI; Carleton BC; Chung WH
    Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):723-734. PubMed ID: 32510242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism.
    Deenen MJ; Cats A; Beijnen JH; Schellens JH
    Oncologist; 2011; 16(6):820-34. PubMed ID: 21632461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.
    Nguyen DV; Vidal C; Chi HC; Do NTQ; Fulton R; Li J; Fernando SL
    HLA; 2017 Dec; 90(6):335-342. PubMed ID: 28884973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.
    Amstutz U; Shear NH; Rieder MJ; Hwang S; Fung V; Nakamura H; Connolly MB; Ito S; Carleton BC;
    Epilepsia; 2014 Apr; 55(4):496-506. PubMed ID: 24597466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
    Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
    Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine.
    López M; Dorado P; Monroy N; Alonso ME; Jung-Cook H; Machín E; Peñas-Lledó E; Llerena A
    Drug Metabol Drug Interact; 2011; 26(1):5-12. PubMed ID: 21557672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistance in epilepsy: a pharmacogenomic update.
    Tate SK; Sisodiya SM
    Expert Opin Pharmacother; 2007 Jul; 8(10):1441-9. PubMed ID: 17661727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A candidate gene study of antiepileptic drug tolerability and efficacy identifies an association of CYP2C9 variants with phenytoin toxicity.
    Depondt C; Godard P; Espel RS; Da Cruz AL; Lienard P; Pandolfo M
    Eur J Neurol; 2011 Sep; 18(9):1159-64. PubMed ID: 21338443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic determinants of platelet response to clopidogrel.
    Kubica A; Kozinski M; Grzesk G; Fabiszak T; Navarese EP; Goch A
    J Thromb Thrombolysis; 2011 Nov; 32(4):459-66. PubMed ID: 21706290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacogenetics and antiepileptic drug metabolism: implication of genetic variants in cytochromes P450].
    Saldaña-Cruz AM; Sánchez-Corona J; Márquez de Santiago DA; García-Zapién AG; Flores-Martínez SE
    Rev Neurol; 2013 May; 56(9):471-9. PubMed ID: 23629749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.
    Scott SA; Martis S; Peter I; Kasai Y; Kornreich R; Desnick RJ
    Pharmacogenomics J; 2012 Aug; 12(4):297-305. PubMed ID: 21358751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients.
    Sukasem C; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Sririttha S; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Puangpetch A; Aekplakorn W
    J Immunol Res; 2018; 2018():2780272. PubMed ID: 29546073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetic determinant of the drug interaction between tacrolimus and omeprazole.
    Zhao W; Fakhoury M; Maisin A; Baudouin V; Storme T; Deschênes G; Jacqz-Aigrain E
    Ther Drug Monit; 2012 Dec; 34(6):739-41. PubMed ID: 23042259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.
    Liang ZY; Han YL; Zhang XL; Li Y; Yan CH; Kang J
    EuroIntervention; 2013 Jul; 9(3):316-27. PubMed ID: 23872648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1.
    Yoo HD; Cho HY; Lee YB
    Br J Clin Pharmacol; 2010 Jan; 69(1):27-37. PubMed ID: 20078610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics: the influence of genomic variation on drug response.
    Thomas FJ; McLeod HL; Watters JW
    Curr Top Med Chem; 2004; 4(13):1399-409. PubMed ID: 15379653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration].
    Huang Y; Yang JF; Qi XL; Wang YQ; Wang WZ; Chen B
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1686-9. PubMed ID: 15569425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Various pharmacogenetic aspects of antiepileptic drug therapy: a review.
    Mann MW; Pons G
    CNS Drugs; 2007; 21(2):143-64. PubMed ID: 17284096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External quality assessment for laboratory testing of HLA-B*15:02 allele in relation to carbamazepine therapy.
    Lin G; Zhang K; Han Y; Xie J; Li J
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28440597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.